Catalyst Biosciences Inc expected to post a loss of 7 cents a share - Earnings Preview

Gyre Therapeutics

12/08/2023 03:04

* Catalyst Biosciences Inc  CBIO.OQ   CBIO.O  is expected
to show
no change in quarterly revenue when it reports  results on
August 14 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Catalyst
Biosciences Inc
is for a loss of 7 cents per share. 
    * The one available analyst rating on the shares is
"hold".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​

This summary was machine generated August 12 at 02:04 GMT.  All
figures in US dollars  unless otherwise stated